Author:
Houseni Mohamed,Hady Mahmoud Abdel Aziz Abdel,Abokoura Sameh
Abstract
Abstract
Objective:
This study’s purpose was to evaluate the response, safety and overall survival of trans-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with preserved hepatic function.
Methods:
This study was carried out on 25 patients, diagnosed with hepatocellular carcinoma (HCC) combined with portal vein tumor thrombosis (PVTT) and underwent hepatic artery infusion chemotherapy (HAIC). Radiological investigations as Triphasic CT or dynamic MRI liver assessment pre and post therapy were acquired. Intra-Arterial chemotherapeutic agent infusion using only doxorubicin was performed.
Results:
Neither of the patients who underwent HAIC developed complete or partial response. Only one patient (4.8%) from 21 patients under HAIC had stable disease. 20 patients (95%) had progressive disease. Progressive disease was in form of progression at the primary tumor site in form of increased focal lesion size, number or vascular invasion. Vascular invasion was seen in one patient (4.8%) in the form of hepatic vein thrombosis. Mean progression free survival was about 2.24 ± 0.88 months. Mean overall survival was about 5.72 ± 0.89 months.
Conclusion:
Our study demonstrated lower clinical efficacy and lower disease control rate of repeated HAIC using doxorubicin only infusion in case of advanced HCC with PVT as compared to combined doxorubicin and cisplatin in previous studies as well as the standard therapy with sorafenib.
Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. Gong L, Li Y, SU Q, et al (2010) Clonality of Nodular Lesions in Liver Cirrhosis and Chromosomal Abnormalities in Monoclonal Nodules of Altered Hepatocytes. Histopathology 56(5):589–599
2. Zhang Z, Guo J, Zhang Z et al (2011) Therapeutic options for intermediate-advanced hepatocellular carcinoma. WJG 17(13):1685–1689
3. Quirk M, Kim Y, H, Saab S, et al (2015) Management of hepatocellular carcinoma with portal vein thrombosis. World J Gastroenterol 21(12):3462–3471
4. Bruix J, Reig M, Sherman M (2016) Evidence-Based Diagnosis, Staging, and Treatment of Patients with Hepatocellular Carcinoma. Gastroenterology 150(4):836–853
5. Silva J, Berger N, Tsai S et al (2017) Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. Review article 19(8):P659-666
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献